Cyient DLM Q3 FY26 Earnings Analysis

- Q4 FY26 expected to see year-on-year growth, driven more by Industrial side than Defence. - Build to Spec (B2S) business is a key focus area with healthy growth and sales pipeline; though mass production primarily starts FY28 onwards, some small orders already in production. - Order book refreshed with better margin revenue, supporting confidence in maintaining and growing double-digit EBITDA margins. - Long-term B2S contracts (some up to 20 years) provide business stability and growth visibility. - Q1 and Q2 have shown good growth momentum expected to accelerate in the rest of FY26 and into FY27. - Diversification efforts targeted at non-A&D sectors including industrial, automotive (especially EV infrastructure), and medical, aiming to broaden customer base. - Strong domestic (India) market growth alongside exports, with exports expected to remain highest contributor. - Overall, momentum points to a revival in year-over-year growth starting H2 FY26 and continuing into FY27.

- Confidence in maintaining and growing double-digit EBITDA margins in the foreseeable future, with current margins just above 10%. - Order book refreshed with higher-margin revenue, indicating quality growth and margin expansion as business scales. - Strong growth expected in Q1 and Q2, with acceleration anticipated for the rest of the year. - Build-to-spec (B2S) business, with long-term contracts (some up to 20 years), provides stable and sustainable revenue streams supporting margin expansion. - Early-stage product development engagements improving value proposition, supply chain control, and margins. - Order intake momentum strong with a book-to-bill ratio above 1.4-1.6, signaling growth in revenues ahead. - Gradual increase in built-to-spec revenue expected, especially in FY27, supporting margin expansion and profitability. - No formal FY27 guidance but early indications suggest a resumption of growth trajectory and sustained profitability improvement.

- Cyient DLM has nearly exhausted IPO funds raised three years ago, with about 93% utilized so far. - The remaining capital expenditure related to the land acquisition in Mysore for building their own factory is still to be spent. - The company is well-positioned with healthy cash reserves to fund future growth opportunities. - Ongoing investments continue in the Build-to-Spec (B2S) business and product-led IP development. - The company is also pursuing inorganic growth opportunities via acquisitions focused on North America and Europe to expand client proximity and enter new industries such as rail and automotive. - Strategic investments are aimed at strengthening existing customer relationships, focusing on domestic market growth, and transforming into a product/IP-led organization.

- There is no mention of any current or planned new fundraising through debt or equity in the document. - The company has nearly exhausted the funds raised during its IPO (93% utilization) as of the third anniversary after the IPO. - Despite utilizing IPO funds, Cyient DLM Limited maintains a healthy cash balance and is comfortably placed to fund any growth internally. - No indications or announcements regarding additional capital raises, either through debt or equity, were disclosed during this quarter or in future guidance.

- Current order book stands at approximately INR 2,300 crores. - The order book has shown continuous growth for the third consecutive quarter. - Order intake in H1 FY26 crossed INR 1,000 crores, reflecting 130% YoY growth. - Book-to-bill ratio for the quarter was 1.6; expected to sustain around 1.4 to 1.5 for the full year. - Over 10% of the current order book is from build-to-spec (B2S) projects, which are long-term and design-led. - Most orders have a duration of 18 to 24 months; B2S orders have a longer gestation but extend up to 9-20 years in some cases. - Approximately 50% of Q1 order intake is expected to be executable in H2 FY26. - New orders include significant wins in automotive and industrial sectors, including electric vehicle infrastructure. - Management expresses confidence about continued order book growth and robust execution throughout FY26 and beyond.